The pathomechanisms underlying oxidative phosphorylation (OXPHOS) diseases are not well-understood, but they involve maladaptive changes in mitochondria-nucleus communication. Many studies on the mitochondria-nucleus cross-talk triggered by mitochondrial dysfunction have focused on the role played by regulatory proteins, while the participation of miRNAs remains poorly explored. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is mostly caused by mutation m.3243A>G in mitochondrial tRNALeu(UUR) gene. Adverse cardiac and neurological events are the commonest causes of early death in m.3243A>G patients. Notably, the incidence of major clinical features associated with this mutation has been correlated to the level of m.3243A>G mutant mitochondrial DNA (heteroplasmy) in skeletal muscle. In this work, we used a transmitochondrial cybrid model of MELAS (100% m.3243A>G mutant mitochondrial DNA) to investigate the participation of miRNAs in the mitochondria-nucleus cross-talk associated with OXPHOS dysfunction. High-throughput analysis of small-RNA-Seq data indicated that expression of 246 miRNAs was significantly altered in MELAS cybrids. Validation of selected miRNAs, including miR-4775 and miR-218-5p, in patient muscle samples revealed miRNAs whose expression declined with high levels of mutant heteroplasmy. We show that miR-218-5p and miR-4775 are direct regulators of fetal cardiac genes such as NODAL, RHOA, ISL1 and RXRB, which are up-regulated in MELAS cybrids and in patient muscle samples with heteroplasmy above 60%. Our data clearly indicate that TGF-β superfamily signaling and an epithelial-mesenchymal transition-like program are activated in MELAS cybrids, and suggest that down-regulation of miRNAs regulating fetal cardiac genes is a risk marker of heart failure in patients with OXPHOS diseases.
The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs / S. Meseguer, J. Panadero, C. Navarro-González, M. Villarroya, R. Boutoual, G.P. Comi, M.-. Armengod. - In: BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE. - ISSN 0925-4439. - 1864:9 Part B(2018 Sep), pp. 3022-3037.
|Titolo:||The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs|
COMI, GIACOMO PIETRO (Penultimo)
|Parole Chiave:||Heteroplasmy; Hypertrophic cardiomyopathy; miR-218-5p; miR-4775; OXPHOS diseases; Cell Line, Tumor; DNA, Mitochondrial; Datasets as Topic; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Developmental; Heart; Heart Failure; High-Throughput Nucleotide Sequencing; Humans; MELAS Syndrome; MicroRNAs; Mitochondria; Muscle, Skeletal; Mutation; Myocardium; Oxidative Phosphorylation; RNA, Transfer, Leu; Sequence Analysis, RNA; Signal Transduction; TGF-beta Superfamily Proteins; Up-Regulation; Molecular Medicine; Molecular Biology|
|Settore Scientifico Disciplinare:||Settore MED/26 - Neurologia|
|Data di pubblicazione:||set-2018|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.bbadis.2018.06.014|
|Appare nelle tipologie:||01 - Articolo su periodico|